[Evaluation of +ondansetron (Zolfiran) in prevention of vomiting in children treated with cytostatics].
The evaluation of Zofran in prevention of chemotherapy induced vomiting was performed in 37 children treated for neoplasms during 167 courses of chemotherapy. Good efficacy was shown in 90% of the evaluated courses. Our results suggest that Zofran is effective and well-tolerated, therefore it should be a drug of choice in prevention of chemotherapy induced vomiting.
Dłuzniewska
A
A
Klinika Hematologii Dzieciecej Polsko-Amerykańskiego Instytutu Pediatrii, Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie.
Balwierz
W
W
Armata
J
J
Eliasińska
A
A
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009369:Neoplasms / Q000628:therapy*; D017294:Ondansetron / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D014839:Vomiting / Q000188:drug therapy* / Q000209:etiology
D017294:Ondansetron
Ocena skuteczności ondansetronu (Zofranu) w zapobieganiu wymiotom u dzieci leczonych cytostatykami.